Wednesday, July 8, 2026

pharma · Triple Negative Breast Cancer (TNBC) · Mesothelin-Expressing Tumors · CNTX

Context Therapeutics

News and analysis for Context Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

Philadelphia, USA HQ
2015 Founded
26 Employees
Public company Type
CNTX · NYSE Ticker
Company details
Status
Public
HQ
Philadelphia, USA
Founded
2015
Employees
26
Programs
8
Drugs
7
Patents
3
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Context Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Context Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Context Therapeutics yet.

Back to company overview →